Quantum-Si (NASDAQ:QSI - Get Free Report) is projected to release its earnings data after the market closes on Thursday, March 6th. Analysts expect Quantum-Si to post earnings of ($0.18) per share and revenue of $1.23 million for the quarter. Persons interested in participating in the company's earnings conference call can do so using this link.
Quantum-Si Trading Up 2.2 %
Quantum-Si stock traded up $0.03 during trading on Friday, reaching $1.38. The company had a trading volume of 6,672,319 shares, compared to its average volume of 24,161,191. The firm has a market capitalization of $196.94 million, a price-to-earnings ratio of -2.16 and a beta of 2.69. The firm's 50-day simple moving average is $2.23 and its 200 day simple moving average is $1.44. Quantum-Si has a 52 week low of $0.61 and a 52 week high of $5.77.
Analyst Ratings Changes
Several research analysts have recently commented on the company. Canaccord Genuity Group decreased their price objective on Quantum-Si from $1.50 to $1.00 and set a "hold" rating on the stock in a research note on Wednesday, November 13th. Alliance Global Partners began coverage on shares of Quantum-Si in a research note on Friday, February 7th. They set a "buy" rating and a $3.75 target price on the stock. Finally, HC Wainwright reaffirmed a "buy" rating and set a $5.50 price target on shares of Quantum-Si in a report on Tuesday, January 14th.
View Our Latest Report on Quantum-Si
Insider Buying and Selling at Quantum-Si
In other news, Director Jonathan M. Rothberg sold 3,506,267 shares of the business's stock in a transaction on Friday, December 27th. The shares were sold at an average price of $3.34, for a total value of $11,710,931.78. Following the transaction, the director now owns 1,250,000 shares of the company's stock, valued at approximately $4,175,000. The trade was a 73.72 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 30.04% of the company's stock.
About Quantum-Si
(
Get Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Featured Stories
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering when you'll finally be able to invest in SpaceX, Starlink, or X.AI? Enter your email address to learn when Elon Musk will let these companies finally IPO.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
